Anika Therapeutics: Q4 Earnings Insights

Anika Therapeutics ANIK reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Anika Therapeutics beat estimated earnings by 8.0%, reporting an EPS of $-0.23 versus an estimate of $-0.25.

Revenue was up $3.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.26 which was followed by a 3.95% increase in the share price the next day.

Here's a look at Anika Therapeutics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.21 -0.06 -0.12 -0.01
EPS Actual 0.05 0.09 0.06 0.12
Revenue Estimate 36.32M 34.76M 32.20M 33.50M
Revenue Actual 39.54M 38.15M 34.29M 32.69M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANIK Logo
ANIKAnika Therapeutics Inc
$11.24-4.50%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
11.29
Growth
7.49
Quality
Not Available
Value
74.82
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...